Biotechnology Stocks I Performance Guide: Regeneron Pharmaceuticals, Inc. (REGN)
REGN has no dividends
Table and Chart of REGN Performance
See what a $1,000 investment in REGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| REGN Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $275.24 |
| End Date | Dec-01-2023 |
| End Price | $814.86 |
| # Prices | 121 |
| Min Date | Dec-31-2013 |
| Min Price | $275.24 |
| Max Date | Aug-31-2023 |
| Max Price | $826.49 |
| Total Return | 196.05% |
| Annualized Return | 11.36% |
| Current Value of $1,000 Purchase | $2,961 |
| Number Returns | 7,260 |
| Average Return | 37.07% |
| Number Profitable Returns | 5,462 |
| Percent Profitable Returns | 75.23% |
| Number Unprofitable Returns | 1,798 |
| Percent Unprofitable Returns | 24.77% |
| Profitable to Unprofitable Returns Ratio | 3.04 |
| REGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $88,776,548,000 | Price to Sales | 6.78 |
| Earnings per Share | $35.0400 |
| PE Ratio | 23.26 |
| PE to Growth Ratio | 1.755 |
| Price to Book | 3.565 |
| PRICE DATA | |
| 52 Week High | $853.97 |
| 52 Week Low | $668 |
| Analyst Target Price | $920.09 |
| 50-Day Moving Average | $813.12 |
| 200-Day Moving Average | $784.41 |
| FINANCIAL DATA | |
| Revenue per Share | $122.63 |
| Revenue | $13,097,300,000 |
| Profit Margin | 30.5% |
| Return on Equity | 0.172% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
REGN Compare Returns with S&P 500
REGN Trendline Chart